Elite Pharmaceuticals Inc (ELTP)

[Sixman]

This thread and Rumoxy is pertinent to ELTP because it again demonstrates yet another potential competitor to the ELTP pipeline as it works towards approval and commercialization of its products.

Viable competition in any of the prospective markets (either IR or ER) suggest that ELTP will have to work harder and/or accept lower margins as it seeks to establish market share.

It's important to not lose sight on the fact that serious, well funded, and well connected competitors exists in this space, and that new entrants must be better and more efficient if they are going to survive, much less be disruptive.